Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 95994

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
December 16, 2024
Product types
Drug
Classifications
Class I
Statuses
Ongoing
Recalling firm wording
SHOPPERS- PLAZA

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7

D-0207-2025
Recall number
D-0207-2025
Initiated
December 16, 2024
Classification
Class I
Status
Ongoing
Recalling firm
SHOPPERS- PLAZA
Quantity
172 180-count bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

Code information

Batch # 001, exp. date 09/10/2026

Distribution pattern

Nationwide via internet sales